These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity. Sudhakar G; Bathula SR; Banerjee R Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876 [TBL] [Abstract][Full Text] [Related]
4. DNA-binding affinity, cytotoxicity, apoptosis, cell cycle inhibition and molecular docking studies of a new stilbene derivative. Mehdipour M; Dehghan G; Yekta R; Hanifeh Ahagh M; Mahdavi M; Ghasemi Z; Fathi Z Nucleosides Nucleotides Nucleic Acids; 2019; 38(2):101-118. PubMed ID: 30931800 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Anti-cancer Activity of Stilbene and Methoxydibenzo[b,f] oxepin Derivatives. Garbicz D; Mielecki D; Wrzesinski M; Pilzys T; Marcinkowski M; Piwowarski J; Debski J; Palak E; Szczecinski P; Krawczyk H; Grzesiuk E Curr Cancer Drug Targets; 2018; 18(7):706-717. PubMed ID: 28669347 [TBL] [Abstract][Full Text] [Related]
8. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones. Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313 [TBL] [Abstract][Full Text] [Related]
10. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents. Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192 [TBL] [Abstract][Full Text] [Related]
11. Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog. Sheldon JE; Dcona MM; Lyons CE; Hackett JC; Hartman MC Org Biomol Chem; 2016 Jan; 14(1):40-9. PubMed ID: 26503632 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents. Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal Inhibitors. Byrd KM; Kent CN; Blagg BSJ ChemMedChem; 2017 Dec; 12(24):2022-2029. PubMed ID: 29058824 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency. Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957 [TBL] [Abstract][Full Text] [Related]
16. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative. Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189 [TBL] [Abstract][Full Text] [Related]
17. New derivatives of 4'-phenyl-2,2':6',2″-terpyridine as promising anticancer agents. Malarz K; Zych D; Gawecki R; Kuczak M; Musioł R; Mrozek-Wilczkiewicz A Eur J Med Chem; 2021 Feb; 212():113032. PubMed ID: 33261897 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents. Srivastava V; Lee H Bioorg Med Chem; 2015 Dec; 23(24):7629-40. PubMed ID: 26602827 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents. Xin YB; Li JJ; Zhang HJ; Ma J; Liu X; Gong GH; Tian YS J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1554-1564. PubMed ID: 30244610 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents. Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]